You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 15, April 21, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Health Agencies Update
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Smallpox Virus Reprieve?

Joan Stephenson, PhD

JAMA. 1999;281:1368.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Preserving stocks of live variola virus may be crucial for making vaccines to protect the public against a possible future outbreak of smallpox caused by a bioterrorist attack, according to a new report from a committee of the Institute of Medicine (IOM).

Although WHO has recommended that these two stocks of variola be destroyed in June, some bioterrorism experts, who believe that the virus has already been distributed to other, possibly less secure, locations in Russia say such an action would be unwise.

"The most compelling need for long-term retention of live variola virus would be for the development of antiviral agents or novel vaccines to protect against a reemergence of smallpox due to accidental or intentional release of variola virus," the report noted.

Copies of the report, Assessment of Future Scientific Needs for Live Variola Virus, will be available in early spring from the National . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.